Insys Hits Ch. 11 After $225M Kickback Settlement
Facing a bevy of lawsuits and declining sales for its flagship opioid, Insys Therapeutics filed for Chapter 11 protection Monday in Delaware with plans to sell the company in a bankruptcy...To view the full article, register now.
Already a subscriber? Click here to view full article